MARATTO

article · Integrative Cancer Therapies

Therapeutic Effect of Camel Milk and Its Exosomes on MCF7 Cells In Vitro and In Vivo

2018157 citationsOpen accessKafr el-Sheikh University

In plain language

Camel milk and exosomes derived from it demonstrate potential as anticancer treatments against MCF7 cancer cells. When evaluated, the milk-derived exosomes exhibited a stronger anticancer effect than whole camel milk, although they triggered a lower immune response. The method of delivery also influenced outcomes, with local injection of the exosomes showing greater improvement compared to oral administration. The observed anticancer activity appears to operate through several cellular mechanisms within the tumour microenvironment. These processes include the induction of programmed cell death, or apoptosis, alongside the suppression of oxidative stress, inflammation, blood vessel formation, and cancer spread. Consequently, both camel milk and its isolated exosomes present viable candidates for further evaluation as therapeutic agents in cancer treatment strategies.

Key takeaways

  • Camel milk-derived exosomes demonstrated a stronger anticancer effect than whole camel milk, while eliciting a lower immune response.
  • Local injection of exosomes resulted in greater therapeutic improvement than oral administration.
  • Anticancer activity appears linked to the induction of apoptosis and the inhibition of oxidative stress, inflammation, angiogenesis, and metastasis.
  • Both camel milk and its exosomes are proposed as potential anticancer agents for cancer therapy.

Why it matters

Finding natural substances that combat tumour growth provides valuable leads for oncology therapeutics. Demonstrating that camel milk and specifically its exosomes can suppress tumour processes such as metastasis, blood vessel formation, and inflammation highlights potential alternative avenues for developing targeted cancer interventions with distinct delivery requirements.

Commercialisation angle

This early-stage research points towards potential pharmaceutical development of camel milk exosomes as oncology therapeutics. Biotechnology or drug formulation developers exploring bio-derived vesicles for local injection could utilise these findings. However, because the work remains at the laboratory stage evaluating MCF7 cells in vitro and in vivo, substantial preclinical validation and clinical testing will be required before any real-world application.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

Overall, administration of camel milk-derived exosomes showed better anticancer effect, but less immune response, than treatment by camel milk. Moreover, local injection of exosomes led to better improvement than oral administration. These findings suggest that camel milk and its exosomes have anticancer effect possibly through induction of apoptosis and inhibition of oxidative stress, inflammation, angiogenesis and metastasis in the tumor microenvironment. Thus, camel milk and its exosomes could be used as an anticancer agent for cancer treatment.

Research topics

  • Animal Diversity and Health Studies
  • Immunotherapy and Immune Responses
  • Curcumin's Biomedical Applications

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1177/1534735418786000

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.